Funded Tech Companies
Rapport Therapeutics
Wondering who backed Rapport Therapeutics? Fidelity Management & Research Company, Third Rock Ventures and Arch Venture Partners invested in this biopharmaceutical company.
Company Overview
Company Name
Rapport Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
201 Brookline Ave 1401
Boston, MA 02215
USA
Boston, MA 02215
USA
Phone
Website
Email Address
Company Background Information
Overview
As a word, Rapport describes relationships characterized by understanding, communication, teamwork, and trust. We reflect those qualities in our daily work, where we operate as one committed team that captures the collective knowledge and experience of all our members to maximally improve patients' lives. And at a higher level we share an ambition and a passion to create impactful neuromedicines, with fewer side effects, that allow patients and their families to live healthier and more fulfilling lives. On a molecular scale, our deep understanding of the intricate relationships between receptors, their associated proteins, and their distributions in specific cell types and brain regions enables us to precisely direct medicines to the neural circuits underlying disease pathophysiology.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
8/23/2023
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Abraham Ceesay
Chief Medical Officer
Brad Galer
Chief Scientific Officer
David Bredt
Company Investors
- Fidelity Management & Research Company
- Third Rock Ventures
- Arch Venture Partners
- Logos Capital
- Sofinnova Ventures
- Johnson & Johnson Innovation
- Cormorant Asset Management
- Perceptive Advisors
- Goldman Sachs
- Surveyor Capital
Browse more funded tech companies:
Share this article
About Our VC Funding Database
This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs